All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| SIOX / Sio Gene Therapies Inc.
|
|
|
|
|
|
|
|
| MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
| PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
| IWM / iShares Trust - iShares Russell 2000 ETF
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| CPHD / Cepheid
|
|
|
|
|
|
|
|
| BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
|
|
|
|
|
|
|
|
| PRTK / Paratek Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| SDS / ProShares Trust - ProShares UltraShort S&P500
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF
|
|
|
|
|
|
|
|
| SNR / New Senior Investment Group Inc
|
|
|
|
|
|
|
|
| IWM / iShares Trust - iShares Russell 2000 ETF Put
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MDCO / Medicines Company
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HOLX / Hologic, Inc.
|
|
|
|
|
|
|
|
| LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| QGEN / Qiagen N.V.
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| IQV / IQVIA Holdings Inc.
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| GSK / GSK plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| CELG / Celgene Corp.
|
|
|
|
|
|
|
|
| IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| IBB / iShares Trust - iShares Biotechnology ETF
|
|
|
|
|
|
|
|
| MTD / Mettler-Toledo International Inc.
|
|
|
|
|
|
|
|
| SGEN / Seagen Inc
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company Call
|
|
|
|
|
|
|
|
